SCHEMBL7784874

SCHEMBL7784874

COC(=O)c1ccc2c(CCCCN3CCN(c4cc5ccc(=O)oc5cc4F)CC3)c[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.48
NPC1 O15118 1/20 0.46
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
HTR1A P08908 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7784875 0.94 SLC6A4 (0.54) SLC6A4ADRA2AADRA2BADRA2CADRA1D
SCHEMBL7784879 0.92 SLC6A4 (0.49) SLC6A4NPC1ADRA2AADRA2BADRA2C
SCHEMBL7784866 0.92 SLC6A4 (0.48) SLC6A4NPC1ADRA2AADRA2BADRA2C
SCHEMBL7780294 0.92 SLC6A4 (0.47) SLC6A4NPC1ADRA2AADRA2BADRA2C
SCHEMBL7780289 0.91 HTR1A (0.45) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL8124382 0.90 HTR1A (0.45) SLC6A4ADRA2AADRA2BADRA2CADRA1D
SCHEMBL7787389 0.90 SLC6A4 (0.47) SLC6A4NPC1ADRA2AADRA2BADRA2C
SCHEMBL7785359 0.88 HTR1A (0.53) SLC6A4ADRA2AADRA2BADRA2CADRA1D
SCHEMBL7787387 0.86 SLC6A4 (0.54) SLC6A4ADRA2AADRA2BADRA2CADRA1D
SCHEMBL7787566 0.86 SLC6A4 (0.56) SLC6A4ADRA2AADRA2BADRA2CADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1093127-C Piperazine derivatives MERCK PATENT GMBH (DE) 2002-10-23 CN disclosed
US-6251908-B1 Piperazine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2001-06-26 US disclosed
CN-1264379-A Piperazine derivatives MERCK PATENT GMBH (DE) 2000-08-23 CN disclosed